Absolute Spectral Power during relaxation (eyes open) 0 h before acute intake at day A

Delta

Theta

Alpha 1

Alpha 2

Beta 1

Beta 2

Subjects

n = 12

n = 12

n = 12

n = 12

n = 12

n = 12

n = 12

n = 12

n = 12

n = 12

n = 12

n = 12

Electrode

Placebo

Verum

Placebo

Verum

Placebo

Verum

Placebo

Verum

Placebo

Verum

Placebo

Verum

Cz

1.21

1.21

0.77

0.85

0.34

0.62

0.51

0.47

0.38

0.42

0.57

0.59

Fz

2.12

2.55

1.30

1.70

0.77

1.17

1.13

0.71

0.62

0.61

0.75

0.84

F3

1.78

1.24

1.24

0.86

0.71

0.60

0.85

0.61

0.93

0.57

1.32

0.95

C3

1.10

0.76

0.77

0.55

0.53

0.48

0.49

0.52

0.65

0.76

1.39

1.00

P3

0.72

0.59

0.47

0.39

0.47

0.42

0.44

0.43

0.56

0.41

0.62

0.48

Pz

0.95

0.96

0.71

0.71

0.48

0.54

0.50

0.51

0.63

0.64

0.69

0.70

P4

0.80

0.75

0.54

0.50

0.44

0.51

0.52

0.60

0.50

0.54

0.58

0.64

C4

0.97

0.88

0.72

0.71

0.49

0.64

0.55

0.72

0.55

0.75

1.06

0.90

F4

1.80

1.47

1.20

1.09

0.59

0.79

0.89

0.59

0.67

0.60

0.80

1.02

F7

5.67

5.45

3.29

2.95

1.48

1.60

1.92

1.22

1.56

1.31

3.32

2.39

T3

3.26

2.50

1.92

1.75

0.95

1.22

1.35

0.91

1.95

1.44

3.85

2.48

T5

1.75

1.89

1.21

1.48

1.00

1.40

1.15

1.39

1.78

1.47

1.54

1.48

O1

1.93

1.66

1.28

1.05

0.64

0.72

0.79

0.65

1.05

0.84

2.19

1.38

O2

1.88

1.58

1.26

0.99

1.04

0.83

0.89

0.91

0.94

0.86

1.33

1.40

T6

2.46

2.00

1.27

1.41

1.08

1.37

0.93

1.47

1.87

1.46

1.82

1.84

T4

2.25

2.64

1.38

1.42

1.09

1.19

1.23

0.97

1.84

1.35

3.27

2.38

F8

5.56

5.46

2.68

2.54

1.37

1.50

1.69

1.10

1.51

1.35

2.65

2.47

Med

1.71

1.57

1.22

0.97

0.80

0.77

0.81

0.67

0.93

0.79

1.32

1.25